Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

302 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The Prognostic Significance of Pretransplant Plasma Fibrinogen Levels in Autologous Hematopoietic Stem Cell Transplantation.
Ogura S, Nakazato T. Ogura S, et al. Among authors: nakazato t. Transplant Proc. 2020 Jun 3:S0041-1345(19)31276-X. doi: 10.1016/j.transproceed.2020.02.153. Online ahead of print. Transplant Proc. 2020. PMID: 32505504
Prognostic Impact of ABO Blood Group on Survival in Patients With Malignant Lymphoma.
Osada Y, Ito C, Nishiyama-Fujita Y, Ogura S, Sakurai A, Akimoto M, Aisa Y, Nakazato T. Osada Y, et al. Among authors: nakazato t. Clin Lymphoma Myeloma Leuk. 2020 Feb;20(2):122-129. doi: 10.1016/j.clml.2019.09.607. Epub 2019 Oct 1. Clin Lymphoma Myeloma Leuk. 2020. PMID: 31917140
Prognostic significance of the modified Barthel index in elderly patients with diffuse large B-cell lymphoma.
Ogura S, Nakazato T. Ogura S, et al. Among authors: nakazato t. Eur J Intern Med. 2020 May;75:110-111. doi: 10.1016/j.ejim.2020.01.021. Epub 2020 Feb 8. Eur J Intern Med. 2020. PMID: 32044179 No abstract available.
Potential role for second‑generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia harboring additional clonal chromosome abnormalities: A retrospective CML Cooperative Study Group analysis.
Ishikawa M, Iriyama N, Tokuhira M, Takaku T, Sato E, Sugimoto KJ, Nakazato T, Fujita H, Kimura Y, Fujioka I, Komatsu N, Asou N, Kizaki M, Hatta Y, Kawaguchi T. Ishikawa M, et al. Among authors: nakazato t. Oncol Rep. 2019 Dec;42(6):2836-2843. doi: 10.3892/or.2019.7339. Epub 2019 Sep 27. Oncol Rep. 2019. PMID: 31578586
Toxoplasmosis after allogeneic hematopoietic stem cell transplantation: Impact of serostatus-based management.
Amikura T, Kikuchi T, Kato J, Koda Y, Sakurai M, Yamazaki R, Mikita K, Saburi M, Nakazato T, Mori T. Amikura T, et al. Among authors: nakazato t. Transpl Infect Dis. 2020 Nov 10:e13506. doi: 10.1111/tid.13506. Online ahead of print. Transpl Infect Dis. 2020. PMID: 33174304
Construction of TUATinsecta database that integrated plant and insect database for screening phytophagous insect metabolic products with medicinal potential.
Nakane W, Nakamura H, Nakazato T, Kaminaga N, Nakano M, Sakamoto T, Nishiko M, Bono H, Ogiwara I, Kitano Y, Iwabuchi K, Kinoshita K, Simpson RJ, Tabunoki H. Nakane W, et al. Among authors: nakazato t. Sci Rep. 2020 Oct 15;10(1):17509. doi: 10.1038/s41598-020-74590-z. Sci Rep. 2020. PMID: 33060804 Free PMC article.
The EUTOS long-term survival score predicts disease-specific mortality and molecular responses among patients with chronic myeloid leukemia in a practice-based cohort.
Sato E, Iriyama N, Tokuhira M, Takaku T, Ishikawa M, Nakazato T, Sugimoto KJ, Fujita H, Kimura Y, Fujioka I, Asou N, Komatsu N, Kizaki M, Hatta Y, Kawaguchi T. Sato E, et al. Among authors: nakazato t. Cancer Med. 2020 Oct 10. doi: 10.1002/cam4.3516. Online ahead of print. Cancer Med. 2020. PMID: 33037866 Free article.
Dose-adjusted EPOCH with or without rituximab for aggressive lymphoma patients: real world data.
Matsuda S, Suzuki R, Takahashi T, Suehiro Y, Tomita N, Izutsu K, Fukuhara N, Imaizumi Y, Shimada K, Nakazato T, Yoshida I, Miyazaki K, Yamaguchi M, Suzumiya J. Matsuda S, et al. Among authors: nakazato t. Int J Hematol. 2020 Dec;112(6):807-816. doi: 10.1007/s12185-020-02984-w. Epub 2020 Sep 3. Int J Hematol. 2020. PMID: 32880824
The prognostic value of the controlling nutritional status score in patients with myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia related changes treated with azacitidine.
Sakurai A, Nakazato T. Sakurai A, et al. Among authors: nakazato t. Leuk Lymphoma. 2020 Dec;61(12):2995-2997. doi: 10.1080/10428194.2020.1791847. Epub 2020 Jul 11. Leuk Lymphoma. 2020. PMID: 32654579 No abstract available.
Pathological Complete Response in Conversion Hepatectomy Induced by Lenvatinib for Advanced Hepatocellular Carcinoma.
Matsuki R, Kawai K, Suzuki Y, Kogure M, Nakazato T, Naruge D, Okano N, Seki S, Ohmori Y, Kawamura N, Kamma H, Hisamatsu T, Shibahara J, Mori T, Furuse J, Sakamoto Y. Matsuki R, et al. Among authors: nakazato t. Liver Cancer. 2020 Jun;9(3):358-360. doi: 10.1159/000506202. Epub 2020 Mar 5. Liver Cancer. 2020. PMID: 32647636 Free PMC article. No abstract available.
302 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback